Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome

被引:68
作者
Brown, Ann J. [1 ]
Setji, Tracy L. [1 ]
Sanders, Linda L. [1 ]
Lowry, Kathryn P. [1 ]
Otvos, James D. [2 ]
Kraus, William E. [1 ]
Svetkey, P. Laura [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] LipoSci Inc, Raleigh, NC USA
关键词
PCOS; CHOLESTEROL; LIPIDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR-MAGNETIC-RESONANCE; LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE ATHEROSCLEROSIS; IMPAIRED GLUCOSE-TOLERANCE; ISCHEMIC-HEART-DISEASE; METABOLIC SYNDROME; CORONARY; RISK; SIZE; PREVALENCE;
D O I
10.1249/MSS.0b013e31818c6c0c
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
BROWN, A. J., T. L. SETJI, L. L. SANDERS, K. P. LOWRY, J. D. OTVOS, W. E. KRAUS, and L, P. SVETKEY. Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome. Med. Sci. Sports Exerc., Vol. 41, No. 3, pp. 497 504, 2009. Purpose: Women with polycystic ovary syndrome (PCOS) commonly have insulin resistance. Insulin resistance is associated with marked abnormalities of lipoprotein size and subclass particle concentration. The purpose Of this Study was to examine the effects of a moderate-intensity exercise program without weight loss on lipoprotein profiles in women with PCOS. Methods: Thirty-seven sedentary PCOS women were randomized to either an 8- to 12-wk ramp-up followed by a 12-wk moderate-intensity exercise program (16-24 wk total, similar to 228 min.wk (1) at 40 60% peak (V) over dotO(2) , n = 21) or control (no change in lifestyle, n = 16). PCOS was defined as <= 8 menses per year and hyperandrogenism (biochemical or clinical with Ferriman-Gallwey score >= 8). Fasting lipoprotein profiles were obtained before and after the intervention. Nuclear magnetic resonance spectroscopy was used to quantify the following: average particle size, total and subclass concentrations of HDL, LDL, and VLDL particles, and Calculated HDL cholesterol. triglycerides, and VLDL triglycerides. Wilcoxon exact rank sums tests were used to compare changes in these parameters in the exercise group relative to controls. Results: Twenty women (8 exercisers, 12 controls) completed the study. Comparing exercisers to controls, significant changes were seen in concentrations of the following lipoprotein parameters that are associated with decreased insulin resistance: decreased large VLDL (P = 0.007), calculated triglycerides (P = 0.003), VLDL triglycerides (P = 0.003), and medium/small HDL (P = 0.031) and increased large HDL (P = 0.002) and average HDL size (P = 0.001). Conclusions: In this trial, moderate-intensity exercise without significant weight loss improved several components of the lipoprotein profiles of women with PCOS. These findings support the beneficial role of moderate exercise in this high-risk population.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 28 条
[1]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[2]   Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome [J].
Berneis, Kaspar ;
Rizzo, Manfredi ;
Lazzaroni, Veronica ;
Fruzzetti, Franca ;
Carmina, Enrico .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) :186-189
[3]   Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome [J].
Christian, RC ;
Dumesic, DA ;
Behrenbeck, T ;
Oberg, AL ;
Sheedy, PF ;
Fitzpatrick, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2562-2568
[4]   Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure - A randomized controlled trial [J].
Church, Timothy S. ;
Earnest, Conrad P. ;
Skinner, James S. ;
Blair, Steven N. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (19) :2081-2091
[5]   Low-density lipoprotein particle number and risk for cardiovascular disease [J].
Cromwell W.C. ;
Otvos J.D. .
Current Atherosclerosis Reports, 2004, 6 (5) :381-387
[6]   Smaller LDL particle size in women with polycystic ovary syndrome compared to controls [J].
Dejager, S ;
Pichard, C ;
Giral, P ;
Bruckert, E ;
Federspield, MC ;
Beucler, I ;
Turpin, G .
CLINICAL ENDOCRINOLOGY, 2001, 54 (04) :455-462
[7]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[8]   Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53
[9]   Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[10]   Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study [J].
Festa, A ;
Williams, K ;
Hanley, AJG ;
Otvos, JD ;
Goff, DC ;
Wagenknecht, LE ;
Haffner, SM .
CIRCULATION, 2005, 111 (25) :3465-3472